Recombinant
Recombinant Anti-delta 1 Catenin/CAS (phospho Y228) antibody [E205] (ab32403)
![Western blot - Anti-delta 1 Catenin/CAS (phospho Y228) antibody [E205] (ab32403)](https://www.abcam.com/ps/products/32/ab32403/Images/ab32403-44720-anti-delta-1-catenin-cas-phospho-y228-antibody-e205-western-blot.jpg "Western blot - Anti-delta 1 Catenin/CAS (phospho Y228) antibody [E205] (ab32403)")
![Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-delta 1 Catenin/CAS (phospho Y228) antibody [E205] (ab32403)](https://www.abcam.com/ps/products/32/ab32403/Images/ab32403-44719-anti-delta-1-catenin-cas-phospho-y228-antibody-e205-immunohistochemistry.jpg "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-delta 1 Catenin/CAS (phospho Y228) antibody [E205] (ab32403)")
Publishing research using ab32403? Please let us know so that we can cite the reference in this datasheet.
ab32403 has been referenced in 3 publications.
- Park SY et al. Glycoprotein 90K Promotes E-Cadherin Degradation in a Cell Density-Dependent Manner via Dissociation of E-Cadherin-p120-Catenin Complex. Int J Mol Sci 18:N/A (2017). PubMed: 29207493
- Surana R et al. IL4 limits the efficacy of tumor-targeted antibody therapy in a murine model. Cancer Immunol Res 2:1103-12 (2014). WB . PubMed: 25204776
- Ma LW et al. Phosphorylated p120-catenin expression has predictive value for oral cancer progression. J Clin Pathol 65:315-9 (2012). PubMed: 22259181